Phase II study to determine the efficacy of bendamustin [bendamustine; Ribomustin] in patients with recurrent small cell bronchial carcinoma after cytostatic polychemotherapy
Latest Information Update: 03 Oct 2021
Price :
$35 *
At a glance
- Drugs Bendamustine (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 13 Nov 2005 New trial record.